Investment bank B. Riley upgraded Core Scientific (CORZ) to buy from neutral, and raised its price target on the shares to $30 from $17, citing strong standalone value and renewed momentum in high-performance computing (HPC).

The bank’s analysts expect shareholders to reject Core Scientific’s proposed merger with CoreWeave (CRWV) s, noting the stock has lagged peers despite being an early mover into HPC.

STORY CONTINUES BELOW
Don’t miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters

Coindesk

Coindesk

BTC NewswireAuthor posts

BTC Newswire Crypto News at your Fingertips

Related Posts ...

Comments are disabled.

BTC-Newswire
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.